Author Details

Cortesi, Paolo Angelo, Research Centre on Public Health (CESP), University of Milano-Bicocca, Monza, Italy, Italy

  • Vol 20, No 1 (2019) - Original research
    The Value and Sustainability of Ocrelizumab in Relapsing Multiple Sclerosis: A Cost-Effectiveness and Budget Impact Analysis
    Abstract  HTML  PDF
  • Vol 22, No 1S (2021) - Supplement
    Health Technology Assessment on the use of the Wearable Cardioverter Defibrillator in Patients with Myocardial Infarction and with ICD Explant
    Abstract  HTML  PDF